Donate to the July 2018 Campaign for the Cure
During our July 2018 Campaign for the Cure, we ask you to support the Cholangiocarcinoma Foundation’s efforts to improve patient care by making a gift today.
Your support will help to initiate an important new awareness program to educate community physicians and patients about genetic testing and clinical trial treatment options.
Five partner organizations are collaborating with CCF to help make this project a success. Each week during the Campaign, we will introduce one of these partners, and describe how their services will have a direct impact on our community.
Fact: 85% of adult cancer patients are seen OUTSIDE of a major cancer center.*
*American Cancer Society
Komodo Health is a healthcare data company that will allow us to directly contact thousands of community physicians across the United States that may not be aware of the Foundation, its patient resources, the importance of genetic testing, and clinical trial treatment options. With help from Komodo, CCF will be able to educate local physicians allowing them to offer more treatment options. Ultimately, this will translate to improved quality of life and better outcomes for patients with cholangiocarcinoma.
“We are excited to partner with the Cholangiocarcinoma Foundation which tirelessly advocates on behalf of patients to find a cure for Cholangiocarcinoma. This partnership is a win for patients—combining the capabilities of Komodo Health’s largest patient-centric healthcare map with CCF’s patient advocates and medical panel to accelerate therapies for an underserved and deadly disease.”Arif Nathoo, MD
Ein Communications will be providing a strategic communications plan, public relations and media outreach for this initiative. Based in Washington, DC, Ein Communications has represented Fortune 100 companies, national media, international law firms, commercial and retail real estate organizations, literary projects, retail, hospitality, healthcare and non-profit associations. With help from Ein Communications, CCF will be able to broadly reach national television, radio, print and e-media outlets to help create awareness among the general public about cholangiocarcinoma.
“We are excited to partner with the Cholangiocarcinoma Foundation which tirelessly advocates on behalf of patients to find a cure for Cholangiocarcinoma. This partnership is a win for patients—combining the capabilities of Komodo Health’s largest patient-centric healthcare map with CCF’s patient advocates and medical panel to accelerate therapies for an underserved and deadly disease.”
DMD specializes in providing highly successful targeted and personalized email campaigns which will effectively communicate our message to healthcare providers. Using industry best practices regarding subject lines, delivery times, and other analytics, they will help to ensure high open and click-through rates from physicians and nurses. This will ensure that as many medical professionals as possible will receive information which could improve treatment outcomes for their patients with cholangiocarcinoma.
“As a committed partner, DMD in collaboration with our colleagues at D2 Creative and Mill Pond Communications are pleased to be an active and contributing member in support of the vitally important work impacting patients and caregivers that the Cholangiocarcinoma Foundation has undertaken regarding genetic testing and clinical trial education initiatives. This work will certainly lead to a better understanding of the disease and more proactive care for appropriate patients supporting life extension.”
Joseph A. Mastracchio